Oral therapy of recombinant Subtilisin QK-2 potentiates thrombolytic effect in a carrageenan-induced thrombosis animal model

Oral therapy of recombinant Subtilisin QK-2 potentiates thrombolytic effect in a carrageenan-induced thrombosis animal model

Thrombosis is a severe health care issue and one of the leading causes of death globally. Since presently used drugs have a number of limitations, safe and effective thrombolytic agents are still needed. Subtilisin QK, widely used as a component of functional food, presents high direct cross-linked...

Full description

Bibliographic Details
Main Authors: Yiping Tang, Yuanyuan Yang, Xuan Lu, Qiuchen Liu, Qiaohong Li, Xia Song, Man Wang, Hankun Hu, Li Zhou, Yefu Wang
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Journal of Functional Foods
Subjects:
Recombinant Subtilisin QK-2
Thrombosis
Fibrinolysis
Thrombolysis
D-dimer
Fibrin/fibrinogen degradation products (FDPs)
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464621005454

Internet

http://www.sciencedirect.com/science/article/pii/S1756464621005454

Similar Items